MetLife Investment Management’s VistaGen Therapeutics VTGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-4,443
| Closed | -$117K | – | 2844 |
|
|
2022
Q2 | $117K | Hold |
4,443
| – | – | ﹤0.01% | 2647 |
|
|
2022
Q1 | $165K | Buy |
4,443
+1,640
| +59% | +$61K | ﹤0.01% | 2466 |
|
|
2021
Q4 | $164K | Hold |
2,803
| – | – | ﹤0.01% | 2175 |
|
|
2021
Q3 | $230K | Hold |
2,803
| – | – | ﹤0.01% | 2003 |
|
|
2021
Q2 | $265K | Buy |
+2,803
| New | +$265K | ﹤0.01% | 1975 |
|